These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13431902)

  • 1. Studies on conversion of phenylalanine to tyrosine in phenylpyruvic oligophrenia.
    WALLACE HW; MOLDAVE K; MEISTER A
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):632-3. PubMed ID: 13431902
    [No Abstract]   [Full Text] [Related]  

  • 2. [Some experiments on phenylalanine- and tyrosine metabolism in a patient with phenylpyruvic oligophrenia].
    HAMANN I
    Maandschr Kindergeneeskd; 1956 Jan; 24(1):28-36. PubMed ID: 13308279
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigations of phenylalanine and tyrosine metabolism in a child with phenylpyruvic oligophrenia].
    HAMANN I
    Z Kinderheilkd; 1956; 78(2):177-84. PubMed ID: 13423485
    [No Abstract]   [Full Text] [Related]  

  • 4. Aminoaciduria and mental retardation. II. Phenylpyruvic oligophrenia, phenylketonuria (PKU).
    ZELLWEGER H
    J Iowa State Med Soc; 1961 Aug; 51():536-40. PubMed ID: 13788179
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylketonuria or phenylpyruvic oligophrenia in the rat: behavioural and biochemical correlates.
    Perez VJ
    J Ment Defic Res; 1965 Sep; 9(3):170-82. PubMed ID: 5892858
    [No Abstract]   [Full Text] [Related]  

  • 6. The hydroxylation of phenylalanine and antipyrine in phenylpyruvic oligophrenia.
    UDENFRIEND S; BESSMAN SP
    J Biol Chem; 1953 Aug; 203(2):961-6. PubMed ID: 13084666
    [No Abstract]   [Full Text] [Related]  

  • 7. A possible mechanism for disturbance in tyrosine metabolism in phenylpyruvic oligophrenia.
    DANCIS J; BALIS ME
    Pediatrics; 1955 Jan; 15(1):63-6. PubMed ID: 13224247
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system.
    JERVIS GA
    Proc Soc Exp Biol Med; 1953 Mar; 82(3):514-5. PubMed ID: 13047448
    [No Abstract]   [Full Text] [Related]  

  • 9. [CONTRIBUTION TO THE STUDY OF MENTAL DEFICIENCY ETIOLOGY IN CASES OF INBORN ERRORS OF PHENYLALANINE METABOLISM].
    GONCERZEWICZ M
    Pediatr Pol; 1965 Mar; 40():259-60. PubMed ID: 14332789
    [No Abstract]   [Full Text] [Related]  

  • 10. The dietary phenylalanine requirements and tolerances of phenylketonuric patients.
    PAINE RS; HSIA DY
    AMA J Dis Child; 1957 Sep; 94(3):224-30. PubMed ID: 13457650
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of 5-hydroxytryptophan decarboxylase by phenylalanine metabolites.
    DAVISON AN; SANDLER M
    Nature; 1958 Jan; 181(4603):186-7. PubMed ID: 13504122
    [No Abstract]   [Full Text] [Related]  

  • 12. Relative inability of mother and child to convert phenylalanine of tyrosine--a possible cause of nonspecific mental retardation.
    Fujimoto A; Crawford R; Bessman SP
    Biochem Med; 1979 Jun; 21(3):271-6. PubMed ID: 496920
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of phenylpyruvic oligophrenia].
    WOLF H
    Medizinische; 1956 Jun; (24):883-6. PubMed ID: 13347861
    [No Abstract]   [Full Text] [Related]  

  • 14. On the nature of enzymatic defect in phenylpyruvic oligophrenia.
    MITOMA C; AULD RM; UDENFRIEND S
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):634-5. PubMed ID: 13431903
    [No Abstract]   [Full Text] [Related]  

  • 15. The problem of phenylketonuria.
    PACHMAN DJ
    Chic Med; 1961 Jun; 63():20. PubMed ID: 13731930
    [No Abstract]   [Full Text] [Related]  

  • 16. The metabolism of indole-compounds in phenvlketonuria.
    HSIA DY; HUANG I
    Cereb Palsy Bull; 1961 Jun; 3():237-43. PubMed ID: 13716363
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the enzymatic and genetic system in phenylalanine metabolism disorders].
    GONCERZEWICZ M
    Pediatr Pol; 1962 Nov; 37():1173-8. PubMed ID: 13948967
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathogenetic aspects of some congenital errors of metabolism].
    CUTILLO S
    Pediatria (Napoli); 1962; 70():x-xvi contd. PubMed ID: 13882811
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia.
    FELLMAN JH
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):413-4. PubMed ID: 13389476
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phenylpyruvic idiocy and tyrosinosis].
    BERGER H
    Bull Schweiz Akad Med Wiss; 1962 Jan; 17():334-40. PubMed ID: 13867655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.